Figure 6.

[⁶⁸Ga]PSMA-11-PET/CT in a patient with prostate cancer initially treated with radiation therapy in 2013 with subsequent biochemical recurrence treated with salvage pelvic radiation therapy. Patient PSA continued to be elevated to 7.7 ng/mL. CT image (A), fused [⁶⁸Ga]PSMA-11-PET/CT (B), [⁶⁸Ga]PSMA-11-PET (C), and whole body MIP (D) images demonstrate increased tracer activity in several enlarged left internal mammary lymph nodes (arrow). (Images courtesy of Tom Hope, MD, University of California San Francisco).